期刊文献+

宫颈浸润癌组织中CD44V6、PCNA、CⅣ表达与转移潜能的关系研究 被引量:7

Expression of CD44V6、PCNA、CⅣ in Cervical Invasion Cancer and Metastasis Potentiality
暂未订购
导出
摘要 目的 探讨CD44V 6、PCNA、CⅣ在宫颈浸润癌组织中的表达与转移潜能的关系。方法 采用免疫组织化学S P法检测 10 4例宫颈浸润癌组织中的CD44V 6、PCNA、CⅣ单克隆抗体表达情况。结果 正常组织对CD44V 6不表达 ;有淋巴结转移的宫颈癌组织对CD44V 6呈过表达 ,阳性率为 81.6% ,无淋巴结转移的宫颈癌组织对CD44V 6呈低表达 ,阳性率为 3 6.4% ;CD44V 6阳性表达组伴有PCNA过表达和CⅣ低表达 ,与CD 44V 6阴性表达组比较有显著性差异。结论 CD 44V 6与肿瘤淋巴结转移有关 ,CD44V 6阳性表达组织可能具有转移潜能。 Objective To study expression of CD44V6、PCNA、CⅣ in the cervical invasion cancer and their metastasis potentiality.Methods Expression of CD44V6、PCNA、CⅣ in 104 case of cervical cancer were detected by immunohistochemistry S P method.Results In normal cervical tissues,there were not expression of CD44V6.In pelvie lympy node metastasis groups,CD44V6 was expressed with a high positive rate of 81.57%.In the group without pelvie lympy node metastasis,a lower positive rate of 36.36% was found.It was significant different between the two groups.In CD44V6 positive groups,the expression of PCNA was high and CⅣ was low,compared with the CD44V6 negative group,it was singificant defferent between the two above groups.Conlusion CD44V6 expression may associate with tumor metastasis.
出处 《实用癌症杂志》 2000年第4期388-390,共3页 The Practical Journal of Cancer
关键词 CD44V6 增殖细胞核抗原 Ⅳ型胶原 宫预癌 Cell adhesion molecule CD44V6 Prolifierating cell nuclear antigen(PCNA) Ⅳ type collagen Cervical carcinoma
  • 相关文献

参考文献1

  • 1William G. Stetler-Stevenson. Type IV collagenases in tumor invasion and metastasis[J] 1990,CANCER AND METASTASIS REVIEW(4):289~303

同被引文献53

  • 1郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:282
  • 2沈蓉,田永杰.MMP-9、TIMP-1在子宫内膜异位症患者子宫内膜中的表达及意义[J].山东医药,2006,46(17):20-22. 被引量:6
  • 3O Down MJ,Philipp E E. The History of Obstetrics and Gynecology. New York: The Part henon Pubiishing Group, 2000. 523-525.
  • 4Afify AM,Craig S,Paulino AF. Temporal variation in the distribution of hyaluronie acid, CD44 s, and CD44v6 in the human endometrium across the enstrual cycle. Appl Immunohistochem Mol Morphol, 2006,14(3): 328
  • 5Thomas L, Byers HR, Vink J, et al. 1 CD44 H regulates tumor allmigration on hyaluronate-eoated substratel,J Cell Biol, 1992, 118(4) :971
  • 6Hofmann UB, Westphal JR, Van Kraats AA, et al. Expression of integrin alpha(v)beta(3)correlates with activation of membranetype matrix metalloproteinase-1 (MT-MMP1) and matrix metalloproteinase-2(MMP-2)in human malanoma cells in vitroand in vivo. Int J Cancer,2000,87(1): 12
  • 7Szamatowicz J, Laudanskip, Tomaszewska I, et al. Matrixmetalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1:a possible role in the pathogenesrs of endometriosis. Hum Reprod, 2002,17(2):284
  • 8Yu Q, Stamenkovie I. Cell surface-Localized matrix metalloproteinase-9 proteolytlcal.ly active TGF-βand promotes tumor invasion and angiogenesis. Genes Dev, 2000,14 : 163
  • 9Bourguignon L Y,Gunja-Smith Z,Iida N,et al. CD44V(3,8-10) isinvolved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase ( MMP-9 ) association in metastatic breas cancer cells. J cell physiol,1998,176(1):206
  • 10Dall P, Heider KH, Sire HP, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression,a new prognostic factor in human breast cancer [J]. Int J Cancer, 1995,60:471- 475.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部